KEI Research Note 2020:2 Role of Private Sector, Governments and Charities in Funding Research and Development Related to Tocilizumab Luis Gil Abinader, May 28, 2020. From the Introduction: The funding of R&D for tocilizumab can be described as having three… Continue Reading
(Updated to include modernatx patents) The biotech company Moderna is in the news this week, after making an announcement of early clinical results for mRNA-1273, a vaccine candidate against novel coronavirus (SARS-CoV-2). The early and partial data are from a… Continue Reading
KEI is an accredited non-state actor at the World Health Organization (WHO). This is our statement at the 73rd World Health Assembly. https://extranet.who.int/nonstateactorsstatements/meetingoutline/6 Knowledge Ecology International Meeting: Seventy-third World Health Assembly Written statements on COVID-19 pandemic The biggest question today… Continue Reading
UPDATE: The World Health Organization has published the COVID-19 response resolution as a conference paper (A73/CONF./1) marked with the date of 18 May 2020. The sponsors of the draft resolution included: Albania, Australia, Bahrain, Bangladesh, Belarus, Bhutan, Bolivia (Plurinational State… Continue Reading
The World Intellectual Property Organization (WIPO) is convening an extraordinary session of the WIPO General Assembly from May 7, 2020 to May 8, 2020; the purpose of this extraordinary session of the General Assembly is to appoint Mr. Daren Tang… Continue Reading
May 4, 2020 Comments of Knowledge Ecology International Regarding “Purple Book Enhancement; Establishment of a Public Docket; Request for Comments” (FDA-2020-N-0437) Knowledge Ecology International (KEI) provides the following comments regarding the Food and Drug Administration [FDA]’s Purple Book Enhancement. Our… Continue Reading
On Monday, 4 May 2020, The European Union convened a virtual pledging marathon, the Coronoavirus Global Response Initiative, in concert with Canada, France, Germany, Italy (incoming G20 presidency), Japan, the Kingdom of Saudi Arabia (current holder of the G20 presidency),… Continue Reading
On April 29, 2020, the United States Trade Representative (USTR) published its annual Special 301 Report. A PDF copy of the report is available here. KEI has compiled copies of the Special 301 Report for every year since its inception… Continue Reading
On Tuesday April 28, 2020, KEI submitted comments to the National Institutes of Health (NIH) regarding the “Prospective Grant of an Exclusive Patent License: AAV Mediated Exendin-4 Gene Transfer to Salivary Glands To Protect Subjects From Diabetes or Obesity” (85… Continue Reading